Sodium-glucose co-transporter 2 inhibitors are a novel class of antihyperglycaemic drugs used in the management of type 2 diabetes, that improve glycaemic control, cardiovascular outcomes and promote weight loss. They are also approved for the treatment of heart failure and chronic kidney disease in patients with or without diabetes. This narrative review discusses the peri-operative effects and implications of sodium-glucose co-transporter 2 inhibitors and gives an overview of current evidence and existing peri-operative guidelines.

中文翻译：

---

钠-葡萄糖协同转运蛋白 2 抑制剂的围手术期意义：叙述性回顾


钠-葡萄糖协同转运蛋白 2 抑制剂是一类用于 2 型糖尿病管理的新型降糖药物，可改善血糖控制、心血管结局并促进体重减轻。它们还被批准用于治疗糖尿病患者或非糖尿病患者的心力衰竭和慢性肾病。本叙述性综述讨论了钠-葡萄糖协同转运蛋白 2 抑制剂的围手术期影响和意义，并概述了当前证据和现有的围手术期指南。